130 related articles for article (PubMed ID: 1618230)
41. Studies of breast cancer imaging with radiolabeled antibodies to carcinoembryonic antigen. Immunomedics Breast Cancer Study Group.
Goldenberg DM; Wegener W
Acta Med Austriaca; 1997; 24(2):55-9. PubMed ID: 9227788
[TBL] [Abstract][Full Text] [Related]
42. Image subtraction analysis with technetium-99M labeled monoclonal antibody and colloid for evaluation of liver lesions. Phantom measurements and patient studies.
Kairemo KJ; Kiuru AJ; Heikkonen JJ
Acta Oncol; 1993; 32(7-8):763-9. PubMed ID: 8305224
[TBL] [Abstract][Full Text] [Related]
43. The value of SPET/CT in chronic osteomyelitis.
Horger M; Eschmann SM; Pfannenberg C; Storek D; Dammann F; Vonthein R; Claussen CD; Bares R
Eur J Nucl Med Mol Imaging; 2003 Dec; 30(12):1665-73. PubMed ID: 14523585
[TBL] [Abstract][Full Text] [Related]
44. Technetium-99 m labelling of DD-3B6/22 antifibrin monoclonal antibody fragment Fab' for thrombus imaging.
Lee FT; Boniface GR; Lambrecht RM; Rylatt DB; Bundesen PG
Immunol Cell Biol; 1993 Apr; 71 ( Pt 2)():117-24. PubMed ID: 8486395
[TBL] [Abstract][Full Text] [Related]
45. Single tumor cell uptake and dosimetry of technetium-99m Fab' or minute anti-CD22 in low-grade B-cell lymphoma.
Lindén O; Hindorf C; Tennvall J; Segrén S; Wingardh K; Strand SE
Cancer; 2002 Feb; 94(4 Suppl):1270-4. PubMed ID: 11877756
[TBL] [Abstract][Full Text] [Related]
46. A false negative by planar scintigraphy liver hemangioma, diagnosed by technetium-99m-red blood cells and technetium-99m-sulfur colloid single photon emission tomography scan.
Zincirkeser S; Celen ZY; Yilmaz M; Topalhan F; Sahin E
Hell J Nucl Med; 2006; 9(2):109-10. PubMed ID: 16894416
[TBL] [Abstract][Full Text] [Related]
47. Comparison of technetium-99m tetrofosmin and gallium-67 citrate scintigraphy for detecting malignant lymphoma.
Yang CC; Sun SS; Lin CC; Kao CH; Lee CC
Anticancer Res; 2001; 21(5):3695-8. PubMed ID: 11848545
[TBL] [Abstract][Full Text] [Related]
48. Comparative diagnostic accuracy of magnetic resonance imaging and immunoscintigraphy for detection of bone marrow involvement in patients with malignant lymphoma.
Altehoefer C; Blum U; Bathmann J; Wüstenberg C; Uhrmeister P; Laubenberger J; Lange W; Schwarzkopf J; Moser E; Langer M
J Clin Oncol; 1997 May; 15(5):1754-60. PubMed ID: 9164182
[TBL] [Abstract][Full Text] [Related]
49. Gallium-67 scintigraphy: a cornerstone in functional imaging of lymphoma.
Even-Sapir E; Israel O
Eur J Nucl Med Mol Imaging; 2003 Jun; 30 Suppl 1():S65-81. PubMed ID: 12644887
[TBL] [Abstract][Full Text] [Related]
50. Preoperative scintigraphy and operative probe scintimetry of colorectal carcinoma using technetium-99m-88BV59.
Moffat FL; Vargas-Cuba RD; Serafini AN; Jabir AM; Sfakianakis GN; Sittler SY; Robinson DS; Crichton VZ; Subramanian R; Murray JH
J Nucl Med; 1995 May; 36(5):738-45. PubMed ID: 7738642
[TBL] [Abstract][Full Text] [Related]
51. Comparison of whole-body 18F-FDG PET, 99mTc-MIBI SPET, and post-therapeutic 131I-Na scintigraphy in the detection of metastatic thyroid cancer.
Iwata M; Kasagi K; Misaki T; Matsumoto K; Iida Y; Ishimori T; Nakamoto Y; Higashi T; Saga T; Konishi J
Eur J Nucl Med Mol Imaging; 2004 Apr; 31(4):491-8. PubMed ID: 14666387
[TBL] [Abstract][Full Text] [Related]
52. Imaging prostate cancer with technetium-99m-7E11-C5.3 (CYT-351).
Chengazi VU; Feneley MR; Ellison D; Stalteri M; Granowski A; Granowska M; Nimmon CC; Mather SJ; Kirby RS; Britton KE
J Nucl Med; 1997 May; 38(5):675-82. PubMed ID: 9170426
[TBL] [Abstract][Full Text] [Related]
53. Internalization and intracellular processing of an anti-B-cell lymphoma monoclonal antibody, LL2.
Shih LB; Lu HH; Xuan H; Goldenberg DM
Int J Cancer; 1994 Feb; 56(4):538-45. PubMed ID: 8112889
[TBL] [Abstract][Full Text] [Related]
54. Monoclonal antibody BW431/26 labelled with technetium 99m and indium 111: an investigation of the biodistribution and the dosimetry in patients.
Benz P; Oberhausen E; Berberich R
Eur J Nucl Med; 1991; 18(10):813-6. PubMed ID: 1743204
[TBL] [Abstract][Full Text] [Related]
55. 99mTc-labeled antihuman epidermal growth factor receptor antibody in patients with tumors of epithelial origin: Part III. Clinical trials safety and diagnostic efficacy.
Ramos-Suzarte M; Rodríguez N; Oliva JP; Iznaga-Escobar N; Perera A; Morales A; Gonzalez N; Cordero M; Torres L; Pimentel G; Borrón M; González J; Torres O; Rodríguez T; Pérez R
J Nucl Med; 1999 May; 40(5):768-75. PubMed ID: 10319748
[TBL] [Abstract][Full Text] [Related]
56. Radioimaging of melanoma using 99mTc-labeled Fab fragment reactive with a high molecular weight melanoma antigen.
Lamki LM; Zukiwski AA; Shanken LJ; Legha SS; Benjamin RS; Plager CE; Salk DF; Schroff RW; Murray JL
Cancer Res; 1990 Feb; 50(3 Suppl):904s-908s. PubMed ID: 2297740
[TBL] [Abstract][Full Text] [Related]
57. 90Y-DOTA-hLL2: an agent for radioimmunotherapy of non-Hodgkin's lymphoma.
Griffiths GL; Govindan SV; Sharkey RM; Fisher DR; Goldenberg DM
J Nucl Med; 2003 Jan; 44(1):77-84. PubMed ID: 12515879
[TBL] [Abstract][Full Text] [Related]
58. Radioimmunodetection of Hodgkin's disease and non-Hodgkin's lymphomas with monoclonal antibody to eosinophil peroxidase.
Samoszuk MK; Anderson AL; Ramzi E; Wang F; Braunstein P; Lutsky J; Majmundar H; Slater LM
J Nucl Med; 1993 Aug; 34(8):1246-53. PubMed ID: 8326380
[TBL] [Abstract][Full Text] [Related]
59. SPECT anti-CEA monoclonal antibody detection of occult colorectal carcinoma metastases.
Swayne LC; Goldenberg DM; Diehl WL; Macaulay RD; Derby LA; Trivino JZ
Clin Nucl Med; 1991 Nov; 16(11):849-52. PubMed ID: 1752096
[TBL] [Abstract][Full Text] [Related]
60. Monitoring bulky mediastinal disease with gallium-67, CT-scan and magnetic resonance imaging in Hodgkin's disease and high-grade non-Hodgkin's lymphoma.
Zinzani PL; Zompatori M; Bendandi M; Battista G; Fanti S; Barbieri E; Gherlinzoni F; Rimondi MR; Frezza G; Pisi P; Merla E; Gozzetti A; Canini R; Monetti N; Babini L; Tura S
Leuk Lymphoma; 1996 Jun; 22(1-2):131-5. PubMed ID: 8724540
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
